Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The efficacy of oral transmucosal fentamyl as an analgesic agent during pan retinal photocoagulation
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN27801757
Date ISRCTN assigned28/09/2007
Local reference number(s)N0025180535
Public titleThe efficacy of oral transmucosal fentamyl as an analgesic agent during pan retinal photocoagulation
Scientific title
AcronymN/A
Disease/condition/study domainEye Diseases: Retinal diseases
Study hypothesisTo determine whether oral transmucosal fentanyl provides effective pain relief during peripheral retinal laser photocoagulation.
Design/methodologyProspective randomised double-masked crossover pilot trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaNot provided at time of registration
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/05/2006
Anticipated end date01/08/2007
Status of trialCompleted
Target number of participants38
InterventionsProspective randomised double-masked crossover pilot trial comparing oral transmucosal fentanyl 200 mcg vs placebo. Patients divided into 2 groups. Stratified randomisation into 2 groups of 19 using random number table. All patients receive laser treatment appropriate to clinical needs, and complete pre-study questionnaire. At each of 2 visits patients will be given a lollipop to suck for 30 minutes prior to laser treatment, the content of the lollipop will be masked. Following each treatment the patient will complete a visual analogue pain score and side effect questionnaire.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingAintree Hospitals NHS Trust
NHS R&D Support Funding
Sponsor nameRecord Provided by the NHSTCT Register - 2007 Update - Department of Health
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameMr David Ian Clark
Contact detailsOphthalmology
Walton Hospital
Rice Lane

Liverpool
United Kingdom
L9 1AE
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN27801757
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central